“The Growing Focus on Biologics and Specialty Pharmaceuticals for Advanced Packaging Films”
- Biologics, including monoclonal antibodies, vaccines, gene therapies, and other protein-based drugs, are inherently more sensitive to environmental conditions than conventional small-molecule drugs.
- They are highly susceptible to degradation from exposure to moisture, oxygen, temperature fluctuations, and light, which can compromise their efficacy, safety, and shelf life.
- Moreover, the complex nature of biologics often requires packaging that accommodates specialized delivery formats, such as pre-filled syringes, auto-injectors, and vials, further pushing the demand for customized and high-performance film solutions.
- The trend toward personalized medicine and targeted therapies also reinforces the need for flexible, small-batch, and precise packaging systems, areas where advanced film technologies play a crucial role.
